# Study of the Duration and Efficacy of MYDAYIS on Adult ADHD Symptoms and Executive Function Throughout the Day Into the Early Evening

> **NCT03945175** · PHASE3 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 52 (actual)

## Conditions studied

- Attention Deficit-Hyperactivity

## Interventions

- **DRUG:** MYDAYIS
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03945175
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-15
- **Primary completion:** 2022-05-11
- **Final completion:** 2022-05-11
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2024-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03945175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03945175, "Study of the Duration and Efficacy of MYDAYIS on Adult ADHD Symptoms and Executive Function Throughout the Day Into the Early Evening". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03945175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*